The impact of COVID-19 vaccination in the US: averted burden of SARS-COV-2-related cases, hospitalizations and deaths
Yamana, T. K.; Galanti, M.; Pei, S.; Di Fusco, M.; Angulo, F. J.; Moran, M.; Khan, F.; Swerdlow, D.; Shaman, J.
Show abstract
By August 1, 2022, the SARS-CoV-2 virus had caused over 90 million cases of COVID-19 and one million deaths in the United States. Since December 2020, SARS-CoV-2 vaccines have been a key component of US pandemic response; however, the impacts of vaccination are not easily quantified. Here, we use a dynamic county-scale metapopulation model to estimate the number of cases, hospitalizations, and deaths averted due to vaccination during the first six months of vaccine availability. We estimate that COVID-19 vaccination was associated with over 8 million fewer confirmed cases, over 120 thousand fewer deaths, and 700 thousand fewer hospitalizations during the first six months of the campaign.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Epidemiological differences in the impact of COVID-19 vaccination in the United States and China 96%
- Modeling the impact of COVID-19 vaccination in Lebanon: A call to speed-up vaccine roll out 94%
- Fall 2021 Resurgence and COVID-19 Seroprevalence in Canada Modelling waning and boosting COVID-19 immunity in Canada A Canadian Immunization Research Network Study 94%
Similar papers in this journal
- Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada 96%
- Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use 96%
- Projecting maximum potential demand for nirsevimab to protect eligible US infants and young children against respiratory syncytial virus in the 2024/2025 season 94%
Similar papers in this journal
- Cost-utility analysis of current COVID-19 vaccination program recommendations in Canada 94%
- Evaluation of statistical models of carriage to predict the impact of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Nigeria 94%
- Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: a modelling study 94%
Similar papers in this journal
- The Joint Impact of COVID-19 Vaccination and Non-Pharmaceutical Interventions on Infections, Hospitalizations, and Mortality: An Agent-Based Simulation 96%
- Identifying silent COVID-19 infections among children is critical for controlling the pandemic 96%
- Estimation of COVID-19 cases prevented by vaccination in California 95%
Similar papers in this journal
- The impact of vaccination on COVID-19 outbreaks in the United States 96%
- Population immunity to SARS-CoV-2 in US states and counties due to infection and vaccination, January 2020-November 2021 94%
- Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.